Literature DB >> 7739025

In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species.

N S Taylor1, J G Fox, L Yan.   

Abstract

Several inbred strains of mice in closed breeding colonies were found to have spiral-shaped bacteria associated with active, chronic hepatitis. A new species of Helicobacter, H. hepaticus, was isolated from the infected livers of some strains of mice. Other strains of mice were colonised with H. hepaticus in the caecum and colon, but not the liver. Filtersterilised supernatant fluid from five strains of H. hepaticus was tested in a mouse liver cell line (ATCC no. CCL 9.1) for cytotoxic activity. All strains produced a toxic factor causing morphological changes in the cells at dilutions up to 1 in 1000. Toxicity was observed after exposure to the supernatant fluid for 48-72 h. Other Helicobacter spp. that also produced the cytopathic effect (CPE) in the liver cell line were H. felis, H. acinonyx, H. pylori and one strain of H. mustelae. "Helicobacter rappini" and H. muridarum did not cause CPE in the liver cells. The soluble factor was stable at 4 degrees C for up to 3 months. It was also stable at 56 degrees C for 30 min, but was inactivated by boiling for 15 min. It was inactivated by incubation with trypsin. A partially purified preparation of the cytotoxin had a mol. wt of c. 100,000 and did not have urease activity. The cytotoxin produced by H. hepaticus did not cause vacuole formation in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739025     DOI: 10.1099/00222615-42-1-48

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  26 in total

1.  Liver disease and Helicobacter.

Authors:  Yu-Qin Luo; Jin-Bo Teng; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

Review 2.  The role of microorganisms in biliary tract disease.

Authors:  Asa Ljungh; Torkel Wadström
Journal:  Curr Gastroenterol Rep       Date:  2002-04

3.  Role of cagA-positive Helicobacter pylori on cell proliferation, apoptosis, and inflammation in biliary cells.

Authors:  Wongwarut Boonyanugomol; Chariya Chomvarin; Seung-Chul Baik; Jea-Young Song; Chariya Hahnvajanawong; Kyung-Mi Kim; Myung-Je Cho; Woo-Kon Lee; Hyung-Lyun Kang; Kwang-Ho Rhee; Banchob Sripa
Journal:  Dig Dis Sci       Date:  2010-12-22       Impact factor: 3.199

4.  Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice.

Authors:  J M Rice
Journal:  Emerg Infect Dis       Date:  1995 Oct-Dec       Impact factor: 6.883

5.  State of the Globe: Helicobacter pylori and Hepatitis C Together Hamper Health.

Authors: 
Journal:  J Glob Infect Dis       Date:  2010-01

6.  Helicobacter pylori and Hepatitis C Virus Coinfection in Egyptian Patients.

Authors:  Samir El-Masry; Mohamed El-Shahat; Gamal Badra; Mohamed F Aboel-Nour; Mahmoud Lotfy
Journal:  J Glob Infect Dis       Date:  2010-01

7.  In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants.

Authors:  Vincent B Young; Kimberly A Knox; Jason S Pratt; Jennifer S Cortez; Linda S Mansfield; Arlin B Rogers; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 8.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

Review 9.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

10.  Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients.

Authors:  Edoardo Giannini; Alberto Fasoli; Federica Botta; Paola Romagnoli; Federica Malfatti; Bruno Chiarbonello; Mario Mamone; Vincenzo Savarino; Roberto Testa
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.